Day One, July 16, 2018


7:15am – 8:00am

Conference Registration & Networking Breakfast


8:00am – 8:15am

Chairperson’s Remarks


8:15am – 9:00am

How Hospitals are Fighting on the Frontlines of the Opioid Crisis

No health system is impervious to the effects of the opioid epidemic raging across the country.  With opioid deaths increasing on a daily basis, the epidemic is clearly worsening.  As such, the health care field is working to reverse the trend and raise awareness of the problem.  Our speakers will discuss the ways hospitals are combating this crisis.  Topics include forming a task force, identifying novel and best practices for prescribing and managing opioids, engaging administrative leaders and physicians, accessing community partners and resources, and collaborating with other hospitals and health systems.


Brian G. Swift, PharmD, MBA

Enterprise Vice President, Chief Pharmacy Officer

Jefferson Health

Associate Dean of Professional Affairs

Jefferson College of Pharmacy

Theodore A. Christopher, MD, FACEP

Chair, Department of Emergency Medicine

Thomas Jefferson University Hospital



9:00am – 9:45am

Reducing the Opioid Addiction Through Health Registries and Electronic Health Records

Surgery is common and appropriate postoperative pain management is critical, as poor management can impair recovery and lead to adverse events including prolonged opioid use and transition to chronic pain. Although pain scores are routinely collected in electronic health records (EHRs), shared algorithms to utilize them for care improvement are limited. One roadblock is that postoperative pain and its related outcomes are complex. The gathering of evidence from EHRs, which draw from and inform real-world practice, help bypass this roadblock and inform decisions that lead to effective and efficient postoperative pain management. Such research enables pain measurement and its management possible across multiple populations and settings, which can provide critical evidence to stakeholders that could move the field away from pain treatment for the ‘average’ patient to pain treatment for an individual. Here we report on evidence from real world data on post-operative pain management in the era of the opioid epidemic.  We present information on opioid prescribing guideline adherence from 2 healthcare settings and present opioid alternatives that offer equivalent pain management. Pain is a common side-effect after any surgical procedure and new evidence highlights the magnitude of the opioid epidemic and suggests prescription opioids contribute significantly to this public health problem. In conclusion, while opioids are an easy way to manage postoperative pain, they may not be the best treatment for all patients.


Tina Hernandez-Boussard

Associate Professor of Medicine, Biomedical Data

Science, and Surgery

Stanford School of Medicine




9:45am – 10:15am

Morning Networking & Refreshments Break


10:15am – 11:00am

CDC Perspective – A Public Health Approach to Opioid Overdose Prevention

This session will discuss the public health approach to opioid overdose prevention as advanced by the Centers for Disease Control and Prevention.  CDC’s efforts are designed to improve data quality and timeliness to better track trends, identify communities at risk, and evaluate prevention strategies; to strengthen state efforts by scaling up effective interventions, particularly those at the community or systems level; and to equip health care providers with the data and tools they need to improve opioid prescribing and improve patient safety. CDC’s Overdose Prevention in States (OPIS) funds state health departments to advance surveillance innovations and to implement and evaluate prevention efforts; examples from these programs will be highlighted.  In addition, the clinical support and resources for the CDC Guideline for Prescribing Opioids for Chronic Pain will be shared, with insights from successful uptake of the Guideline.



Sarah Bacon, PhD

Lead Behavioral Scientist

Prescription Drug Overdose State Support Team

Division of Unintentional Injury Prevention

Center for Disease Control and Prevention


11:00am – 11:45am

How the Substance Abuse and Mental Health Services Administration (SAMHSA) is Responding to the Opioid Epidemic

With the opioid addiction problem in the United States continuing to rise, it is important for prescribers to educate themselves in substance abuse prevention. This session will discuss how health providers can use specific strategies to help reduce drug addiction. Strategies covered will include:
-       Using Prescription Drub Monitoring Programs (PDMPs) as patient safety tools
-       Screening, Brief Intervention and Referral to Treatment (SBIRT)
-       Establishing referral relationships with addiction treatment providers and social services programs in the community
-       Overcoming barriers to incorporating screening for addiction problems


Anthony Campbell, RPH, DO, FACP, CDR, USP

Medical Officer

Center for Substance Abuse Treatment

Division of Pharmacologic Therapies

Substance Abuse and Mental Health Service

Administration (SAMHSA)



11:45am – 12:45pm



12:45pm – 1:30pm

How Pharmacy Benefit Managers (PBMs) and Pharmacists Can Manage Opioid Prescribing

This session will embark on how PBMs can help to reduce the overprescribing and misuse of opioid medications. This program will cover the following:
-       How to evaluate opioid utilization data and leverage enhanced utilization management strategies to reinforce prescribing best practices and dispensing guidelines
-       “Red flags” to alert dispensing pharmacists of potential opioid overuse/abuse
-       Non-compliance due to repeated attempts of early refills
-       Locking a patient into using a single opioid prescriber/pharmacy when system shows multiple prescribing physicians prescribing the same drug
-       Academic detailing approaches to collaboratively partner with prescribers on safe opioid dose titration and patient support strategies
-       Facilitating safe opioid storage and disposal
-       Improving access to and education on the importance and proper usage of naloxone
-       Leveraging digital solutions to improve pain management and patient support


Steve Cutts, PharmD, Rph

Vice President, Pharmacy Services

and Clinical Strategy

Magellan Rx



1:30pm – 2:15pm

Battling the Opioid Epidemic with Clinical Communities: A Health System’s Approach to Opioid Stewardship

Based on CDC data, more than 45,000 people died from opioid overdose in the past 12 months. Healthcare systems, which integrate networks of hospitals, clinics, and emergency rooms, have the capacity to change the landscape in terms of opioid prescribing and overdose deaths.  The Johns Hopkins Health System Opioid Stewardship Clinical Community was formed to implement best practices and generate solutions backed by science to address the opioid epidemic, with four key areas to target for intervention:
-       Decreasing excess exposure to opioids through judicious opioid prescribing
-       Educating of patients, clinicians, and others in the health system
-       Implementing quality metrics and analytics
-       Advocating for policies and regulation in support of opioid stewardship


Through the work of the clinical community, Johns Hopkins has improved the safety of opioid prescribing, standardized practices via electronic health record and order entry systems, and deployed evidence-based education to patients and providers.


Mark Bicket, MD

Director, Pain Medicine Fellowship Program

Assistant Professor

Johns Hopkins University School of Medicine


2:15pm – 2:45pm

Afternoon Networking & Refreshments Break


2:45pm – 3:45pm

Panel: Implementing Strategies to Prevent Opioid Abuse - Building an Effective Continuum of Care for Opioid Use Disorder

Opioid use disorder is a chronic illness which can have remissions over time. To prevent readmissions related to this disorder, health systems need to apply the well-known concept of continuum of care for the management of opioid use disorder. There are many deficiencies of acute and long-term treatment and recovery support for patients dealing with substance abuse disorders. This session will discuss the following:
-       State programs that introduce recovery coaches in the ER
-       Expansion of Medication Assisted Treatment (MAT) with individual providers and clinics
-       Introducing Project ECHO in support of Opioid treatment
-       Describe how to implement these practices across your health system
-       Define prevention, treatment and recovery within the continuum of care model
-       Provide examples of how strategies are being applied for each of these components


Daniel Schwarz, MD, ABAM, FASAM

CLIA High Complexity Toxicologist


The Center for Pain Recovery, MI

Chief Medical Officer

Full Circle to Completion, OH

Brian G. Swift, PharmD, MBA

Enterprise Vice President, Chief Pharmacy Officer

Jefferson Health

Associate Dean of Professional Affairs

Jefferson College of Pharmacy

Theodore A. Christopher, MD, FACEP

Chair, Department of Emergency Medicine

Thomas Jefferson University Hospital


Elizabeth Collier, MSW, CSAC, ICS, LCSW

State Opioid Treatment Authority

Division of Care and Treatment Services

Bureau of Prevention Treatment and Recovery

Wisconsin Department of Health Services


3:45pm – 4:30pm

Medicaid and Addiction Treatment - Tackling the Opioid Epidemic: Strategies and Initiatives for Success

Medicaid programs are at the center of the opioid crisis. A higher percentage of adults covered by Medicaid are prescribed painkillers at higher rates than non-Medicaid patients. This topic will also discuss:
-       How Medicaid programs are implementing a range of policies to regulate and reduce prescription opioid use
-       How Medicaid programs are responding to the changing landscape
-       Patient review and restriction
-       Preferred drug lists
-       Prescription drug monitoring programs (PDMPs)
-       Requirements for prior authorizations
-       Limiting quantity on opioid dispensing
-       CMS’ new Section 1115 waiver which would allow stat Medicaid programs to reimburse for substance abuse treatment provided at inpatient facilities with more than 16 beds otherwise prohibited by the current Institutions for Mental Diseases exclusion.


4:30pm – 5:15pm

Five Stages to Discontinuing Opioids: Conversations to De-escalate, Discontinue or Deprescribe Opioids for Chronic Pain

This session focuses on how to have the difficult conversation when opioids are no longer an option for chronic pain. Objectives include opioid de-escalation, post-opioid management, and non-opioid treatment options for patients suffering adverse effects, displaying aberrant behavior, or failing to meet therapeutic goals. This educational workshop and tool was mirrored after literature on grief and CDC clinical guidelines to aid in understanding emotional processing as patients ‘grieve’ changes in treatment. Clinicians will be instructed on a successful approach for the aforementioned treatment hurdles.


Kevin W. Chamberlin, PharmD, FASCP

Associate Clinical Professor & Assistant

Department Head, Pharmacy Practice, Residency

Program Director

University of Connecticut School of Pharmacy,

UConn Health


Rebecca Andrews, MS, MD FACP

Director of Ambulatory Education

Associate Program Director, Internal Medicine Residency

Associate Professor of Medicine

CT Institute of Primary Care Innovation



End of Day One


Executive Business Intelligence Forum


General Info 


tel: (800) 260 - 9715

Sponsorship Opportunities


Go to top